Logo image
Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah's Witness using chemotherapy free regimen: A case report and review of literature
Journal article   Open access   Peer reviewed

Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah's Witness using chemotherapy free regimen: A case report and review of literature

Muhammad Hassan Raza, Eiraj Khan, Alexis M. Desjarlais and Salman Fazal
Leukemia research reports, v 24, 100517
01 Jan 2025
PMID: 40612022
url
https://doi.org/10.1016/j.lrr.2025.100517View
Published, Version of Record (VoR) Open

Abstract

All Allo-SCT Cameroon CSAs ESAs HSCT MRD TKI TSAs
Introduction and Importance: Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (pH-positive ALL) in Jehovah's Witness (JW) using chemotherapy agents, opens an ethically and morally challenging paradigm instead of their religious practices. Case Presentation: We present a case of pH-positive B cell ALL in a Jehovah's Witness patient who refused the transfusion of blood as a part of their treatment regimen. We intended to treat this patient using a new “chemotherapy-free” approach and achieved Minimal Residual Disease (MRD) negative state with durable outcomes for the next three years. Clinical Discussion: With “chemotherapy-free” regimen, we achieved complete molecular remission without any significant side effects in our patient. Conclusion: Chemo-free approach is a promising opportunity to treat Jehovah's witnesses with pH-positive B cell ALL as the haemoglobin and platelets remained above transfusion thresholds. However, further research is required to fully understand and implement this approach. Future clinical trials should consider including this unique patient population to better understand their needs and improve outcomes.

Metrics

1 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Hematology
Oncology
Logo image